Ads
related to: when to treat pulmonary hypertension- PAH Signs and Symptoms
Find Info on Common Symptoms
That Are Attributable to PAH.
- Dosing & Administration
View Full Prescribing and
Safety Information.
- Coverage & Access
Visit Site to Review Coverage
& Access Info for Patients.
- Important Safety Info
View Important Safety Information
at the HCP Site.
- Patient Profile
Watch Video and Read to
Learn About Patient Journeys.
- Clinical Trial Info
Visit Site to View Clinical Trial
and Safety Information.
- PAH Signs and Symptoms
Search results
Results From The WOW.Com Content Network
Treatment of pulmonary hypertension is determined by whether the PH is arterial, venous, hypoxic, thromboembolic, or miscellaneous. If it is caused by left heart disease, the treatment is to optimize left ventricular function by the use of medication or to repair/replace the mitral valve or aortic valve. [68]
A pulmonary artery wedge pressure being less than 15 mmHg (also measured by right heart catheterization) excludes post-capillary bed (in the veins distal to the capillary bed) pulmonary hypertension. Pulmonary arterial hypertension is a subgroup of pulmonary hypertension and is categorized as World Health Organization as group 1. [3]
Iloprost, sold under the brand name Ventavis among others, is a medication used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon, frostbite, and other conditions in which the blood vessels are constricted and blood cannot flow to the tissues. [4] Iloprost is a prostacyclin mimetic. [1]
Winrevair was approved to treat pulmonary arterial hypertension (PAH), a progressive disorder caused by a constriction of arteries in the lungs, leading to symptoms such as shortness of breath ...
Ambrisentan, sold under the brand name Letairis among others, is a drug used for the treatment of pulmonary hypertension. [3] [5] It is an endothelin receptor antagonist. [3] The peptide endothelin constricts muscles in blood vessels, increasing blood pressure.
About 1% of the global population has pulmonary hypertension, which currently has no cure. The condition is more common in females, and scientists believe it may be due to the hormone estrogen.
Ads
related to: when to treat pulmonary hypertension